APOMORPHINE HYDROCHLORIDE

APOMORPHINE HYDROCHLORIDE was reported 1689 times

APOMORPHINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CEREBRAL HYPOPERFUSION 73 0.1567
1 MEDICAL DEVICE SITE HYPERSENSITIVITY 1 0.1250
2 BINOCULAR EYE MOVEMENT DISORDER 35 0.1215
3 ADMINISTRATION SITE NECROSIS 4 0.1000
4 CEREBELLAR STROKE 35 0.0895
5 BLOOD COBALT INCREASED 1 0.0833
6 ADMINISTRATION SITE NODULE 5 0.0833
7 BEHAVIOURAL THERAPY 2 0.0667
8 INFUSION SITE NODULE 64 0.0666
9 APPLICATION SITE NECROSIS 6 0.0583
10 INFUSION SITE NECROSIS 11 0.0573
11 INFUSION SITE IRRITATION 61 0.0475
12 DEVICE PRIMING 1 0.0435
13 ADMINISTRATION SITE ULCER 1 0.0417
14 INJECTION SITE JOINT ERYTHEMA 1 0.0400
15 BLOOD CHROMIUM INCREASED 1 0.0370
16 COLOSTOMY BAG USER 1 0.0286
17 ADMINISTRATION SITE HAEMATOMA 1 0.0250
18 PELVIC FLOOR DYSSYNERGIA 1 0.0238
19 INJECTION SITE NECROSIS 43 0.0211
20 IDIOPATHIC ENVIRONMENTAL INTOLERANCE 1 0.0204
21 POST MICTURITION DRIBBLE 1 0.0204
22 ADMINISTRATION SITE WOUND 2 0.0202
23 CELL-MEDIATED CYTOTOXICITY 1 0.0196
24 HYPORESPONSIVE TO STIMULI 23 0.0196
25 DOPAMINE AGONIST WITHDRAWAL SYNDROME 1 0.0185
26 APPLICATION SITE ABSCESS 1 0.0172
27 FREEZING PHENOMENON 56 0.0151
28 COOMBS TEST POSITIVE 4 0.0147
29 APPLICATION SITE NODULE 2 0.0146
30 CAFFEINE CONSUMPTION 1 0.0145
31 INFUSION SITE BRUISING 29 0.0134
32 INFUSION SITE HAEMORRHAGE 43 0.0131
33 OVARIAN GERM CELL TERATOMA 1 0.0125
34 APPLICATION SITE WOUND 2 0.0121
35 APPLICATION SITE INDURATION 2 0.0118
36 INFUSION SITE ERYTHEMA 99 0.0117
37 SLOW RESPONSE TO STIMULI 15 0.0116
38 INFUSION SITE INJURY 2 0.0114
39 INFUSION SITE PRURITUS 35 0.0111
40 ON AND OFF PHENOMENON 60 0.0108
41 INFUSION SITE PAPULE 1 0.0105
42 INFUSION SITE REACTION 31 0.0104
43 INFUSION SITE COLDNESS 1 0.0100
44 INJECTION SITE NODULE 101 0.0092
45 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 4 0.0087
46 INFUSION SITE SWELLING 54 0.0086
47 INFUSION SITE INFLAMMATION 6 0.0085
48 INFUSION SITE HAEMATOMA 4 0.0084
49 CAMPTOCORMIA 2 0.0083
50 STOMA SITE EXTRAVASATION 3 0.0078
51 DRUG WITHDRAWAL MAINTENANCE THERAPY 1 0.0071
52 ENDOSCOPY UPPER GASTROINTESTINAL TRACT 1 0.0068
53 DOPAMINE DYSREGULATION SYNDROME 3 0.0067
54 INJECTION SITE IRRITATION 84 0.0066
55 MALABSORPTION FROM INJECTION SITE 2 0.0065
56 SEXUALLY INAPPROPRIATE BEHAVIOUR 3 0.0064
57 COOMBS DIRECT TEST POSITIVE 2 0.0064
58 BRACHIAL PLEXUS INJURY 1 0.0062
59 HYPERBARIC OXYGEN THERAPY 1 0.0060
60 LITHOTRIPSY 1 0.0059
61 MEDICAL DEVICE SITE SWELLING 1 0.0058
62 INFUSION SITE CELLULITIS 3 0.0057
63 DEVICE ALARM ISSUE 10 0.0055
64 JEJUNOSTOMY 1 0.0055
65 DYSKINESIA 219 0.0054
66 PHYSICAL ABUSE 1 0.0052
67 CHEMICAL PERITONITIS 1 0.0051
68 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 2 0.0050
69 PARKINSONIAN GAIT 3 0.0048
70 HYPERKINESIA 10 0.0047
71 YAWNING 12 0.0045
72 INFUSION SITE URTICARIA 3 0.0045
73 HYPERSEXUALITY 8 0.0044
74 SOFT TISSUE MASS 2 0.0043
75 INJECTION SITE GRANULOMA 1 0.0042
76 WOUND NECROSIS 2 0.0042
77 STOMA SITE PAIN 6 0.0041
78 FRUSTRATION TOLERANCE DECREASED 33 0.0041
79 INFUSION SITE WARMTH 5 0.0041
80 HYPERMOBILITY SYNDROME 2 0.0040
81 SKULL FRACTURED BASE 1 0.0040
82 INFUSION SITE ABSCESS 2 0.0040
83 INJECTION SITE INFECTION 13 0.0040
84 PSYCHOTIC BEHAVIOUR 4 0.0039
85 APPLICATION SITE INFECTION 2 0.0039
86 HAEMOLYTIC ANAEMIA 35 0.0039
87 INFUSION SITE INFECTION 9 0.0039
88 CYANOSIS CENTRAL 1 0.0038
89 COMPULSIVE SEXUAL BEHAVIOUR 3 0.0037
90 INFUSION SITE MASS 4 0.0037
91 VERTEBRAL FORAMINAL STENOSIS 3 0.0036
92 NODULE 47 0.0036
93 ENTERAL NUTRITION 2 0.0034
94 ORTHOSTATIC HYPERTENSION 2 0.0034
95 PANNICULITIS 8 0.0033
96 MICTURITION URGENCY 37 0.0032
97 RENAL HYPERTENSION 1 0.0032
98 INJECTION SITE ABSCESS 8 0.0032
99 STOMA SITE HYPERGRANULATION 2 0.0032
100 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
101 CATHETER SITE BRUISE 1 0.0030
102 INJECTION SITE INFLAMMATION 15 0.0030
103 BLOOD PRESSURE ORTHOSTATIC DECREASED 1 0.0029
104 INFUSION SITE RASH 4 0.0029
105 PSEUDOSTROKE 1 0.0029
106 NOCTURIA 35 0.0029
107 SKIN MASS 19 0.0028
108 NASAL INJURY 2 0.0028
109 FEEDING TUBE USER 1 0.0027
110 PATIENT ELOPEMENT 1 0.0027
111 INFUSION SITE INDURATION 4 0.0027
112 STOMA SITE ERYTHEMA 5 0.0027
113 PERIPROSTHETIC FRACTURE 1 0.0026
114 AUTOIMMUNE HAEMOLYTIC ANAEMIA 9 0.0026
115 IMPAIRED REASONING 1 0.0026
116 SKIN NECROSIS 13 0.0025
117 DEVICE COLOUR ISSUE 1 0.0025
118 HYPOXIC ENCEPHALOPATHY 1 0.0024
119 ANAEMIA HAEMOLYTIC AUTOIMMUNE 2 0.0024
120 DEVICE OCCLUSION 34 0.0024
121 INTESTINAL PROLAPSE 1 0.0024
122 RECALL PHENOMENON 2 0.0024
123 DEVICE CONNECTION ISSUE 5 0.0024
124 COLONOSCOPY ABNORMAL 1 0.0023
125 FEELING COLD 64 0.0023
126 INFUSION SITE DISCOLOURATION 2 0.0023
127 METASTASES TO PANCREAS 1 0.0023
128 HALLUCINATION 165 0.0022
129 GENERAL SYMPTOM 16 0.0021
130 HEPATIC HAEMATOMA 1 0.0021
131 OCULAR NEOPLASM 1 0.0021
132 INTERVERTEBRAL DISC INJURY 1 0.0021
133 OPEN FRACTURE 1 0.0021
134 PRE-EXISTING DISEASE 1 0.0021
135 DEVICE POWER SOURCE ISSUE 6 0.0021
136 BRAIN STEM STROKE 1 0.0020
137 EAR INJURY 1 0.0020
138 SPUTUM RETENTION 2 0.0020
139 TESTICULAR DISORDER 2 0.0020
140 CYST REMOVAL 1 0.0019
141 DEVICE KINK 7 0.0019
142 INTERVERTEBRAL DISC DISPLACEMENT 1 0.0019
143 SCAPULA FRACTURE 1 0.0019
144 INFUSION SITE VESICLES 1 0.0019
145 BRADYKINESIA 11 0.0019
146 PRODUCT NAME CONFUSION 2 0.0018
147 ILLUSION 3 0.0018
148 SPEECH DISORDER 94 0.0018
149 REPETITIVE SPEECH 1 0.0018
150 MEDICAL DEVICE SITE PAIN 1 0.0018
151 PRESYNCOPE 43 0.0018
152 NAIL BED BLEEDING 1 0.0018
153 HEAD BANGING 1 0.0018
154 COLON INJURY 1 0.0017
155 DROOLING 12 0.0017
156 NASAL MUCOSAL DISORDER 1 0.0017
157 INDURATION 3 0.0017
158 BRAIN FOG 26 0.0017
159 FAT NECROSIS 1 0.0016
160 INFUSION SITE PAIN 21 0.0016
161 SITTING DISABILITY 1 0.0016
162 DEVICE INFUSION ISSUE 4 0.0016
163 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
164 INFREQUENT BOWEL MOVEMENTS 4 0.0016
165 HEPATOBILIARY DISEASE 1 0.0016
166 BLOOD PRESSURE MEASUREMENT 1 0.0016
167 THERAPEUTIC PRODUCT EFFECT VARIABLE 6 0.0015
168 ENTEROCOCCUS TEST POSITIVE 1 0.0015
169 ABDOMINAL WALL ABSCESS 1 0.0015
170 NEURALGIA 37 0.0015
171 COMPULSIONS 1 0.0015
172 CYSTITIS NONINFECTIVE 2 0.0015
173 DIPLOPIA 38 0.0015
174 HICCUPS 12 0.0015
175 IMPULSE-CONTROL DISORDER 3 0.0015
176 AKINESIA 3 0.0014
177 SUDDEN ONSET OF SLEEP 2 0.0014
178 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
179 BRONCHIAL OBSTRUCTION 2 0.0014
180 HALLUCINATION, VISUAL 30 0.0014
181 DYSTONIA 27 0.0014
182 SOMNOLENCE 279 0.0014
183 BLOOD FOLATE DECREASED 1 0.0014
184 GINGIVAL ABSCESS 1 0.0013
185 MALIGNANT ASCITES 1 0.0013
186 STOMA SITE HAEMORRHAGE 2 0.0013
187 DAYDREAMING 2 0.0013
188 DEVICE DEFECTIVE 22 0.0013
189 MUSCLE RIGIDITY 15 0.0013
190 HAEMOPERITONEUM 1 0.0012
191 DYSARTHRIA 47 0.0012
192 PRODUCT LEAKAGE 7 0.0012
193 HAPTOGLOBIN DECREASED 1 0.0012
194 POSTURE ABNORMAL 4 0.0012
195 PERSECUTORY DELUSION 3 0.0012
196 SALIVARY HYPERSECRETION 12 0.0012
197 DENTAL DISCOMFORT 1 0.0012
198 ATONIC SEIZURES 1 0.0012
199 DEVICE LOOSENING 1 0.0012
200 ABSCESS DRAINAGE 1 0.0012
201 HILAR LYMPHADENOPATHY 1 0.0011
202 ABDOMINAL NEOPLASM 1 0.0011
203 CATARRH 1 0.0011
204 DECUBITUS ULCER 9 0.0011
205 INJECTION SITE ERYTHEMA 135 0.0011
206 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
207 INJECTION SITE ULCER 1 0.0011
208 BRAIN STEM HAEMORRHAGE 1 0.0011
209 FACE INJURY 4 0.0011
210 ELECTROCARDIOGRAM CHANGE 1 0.0011
211 MOTION SICKNESS 2 0.0010
212 ORTHOSTATIC HYPOTENSION 18 0.0010
213 BLADDER CATHETERISATION 1 0.0010
214 REHABILITATION THERAPY 4 0.0010
215 ALCOHOL INTERACTION 2 0.0010
216 APPLICATION SITE BRUISE 1 0.0010
217 ABDOMINAL WALL HAEMATOMA 2 0.0010
218 PRODUCT MEASURED POTENCY ISSUE 1 0.0010
219 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
220 LIBIDO INCREASED 2 0.0010
221 REDUCED FACIAL EXPRESSION 1 0.0010
222 ARTHRODESIS 1 0.0010
223 CONSCIOUSNESS FLUCTUATING 1 0.0010
224 HYPOPERFUSION 1 0.0010
225 NON-CARDIOGENIC PULMONARY OEDEMA 1 0.0009
226 BALANCE DISORDER 81 0.0009
227 PANCREATIC MASS 1 0.0009
228 DEVICE INEFFECTIVE 1 0.0009
229 BEHAVIOUR DISORDER 5 0.0009
230 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
231 SOMNAMBULISM 6 0.0009
232 ABDOMINAL ABSCESS 4 0.0009
233 DEMENTIA WITH LEWY BODIES 1 0.0009
234 LARYNGEAL CANCER 1 0.0009
235 NECROSIS 5 0.0009
236 DRUG EFFECT VARIABLE 1 0.0009
237 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 15 0.0009
238 DISTRACTIBILITY 1 0.0009
239 INJECTION SITE SWELLING 66 0.0009
240 GAMBLING 1 0.0009
241 SENSE OF OPPRESSION 1 0.0008
242 INJECTION SITE INDURATION 11 0.0008
243 COLON OPERATION 1 0.0008
244 MULTIMORBIDITY 1 0.0008
245 DIZZINESS POSTURAL 8 0.0008
246 PRODUCT CONTAINER ISSUE 7 0.0008
247 MOVEMENT DISORDER 26 0.0008
248 INTERVERTEBRAL DISC OPERATION 1 0.0008
249 IMPULSIVE BEHAVIOUR 3 0.0008
250 NASAL PRURITUS 1 0.0008
251 FRACTURED COCCYX 1 0.0008
252 GASTRIC ULCER PERFORATION 1 0.0008
253 OBSTRUCTION GASTRIC 1 0.0008
254 PALLOR 21 0.0008
255 CATATONIA 4 0.0008
256 PRODUCT DISTRIBUTION ISSUE 7 0.0008
257 HYPOTENSION 150 0.0007
258 LARYNGOSPASM 2 0.0007
259 ENURESIS 3 0.0007
260 APPLICATION SITE INFLAMMATION 1 0.0007
261 ELECTRIC SHOCK SENSATION 2 0.0007
262 INTENSIVE CARE 1 0.0007
263 DERMATITIS CONTACT 8 0.0007
264 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
265 VOMITING PROJECTILE 2 0.0007
266 INJECTION SITE PRURITUS 46 0.0007
267 PSYCHOTIC DISORDER 20 0.0007
268 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
269 IMPETIGO 1 0.0007
270 MENTAL FATIGUE 1 0.0007
271 DEVICE ISSUE 59 0.0007
272 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
273 PALLIATIVE CARE 1 0.0007
274 DEVICE PHYSICAL PROPERTY ISSUE 5 0.0007
275 HAEMOLYSIS 5 0.0006
276 DEVICE BREAKAGE 26 0.0006
277 ENTHESOPATHY 1 0.0006
278 DYSPHONIA 37 0.0006
279 SCREAMING 4 0.0006
280 SUBCUTANEOUS ABSCESS 3 0.0006
281 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
282 INCOHERENT 4 0.0006
283 FALL 205 0.0006
284 SHOULDER FRACTURE 1 0.0006
285 OXYGEN THERAPY 1 0.0006
286 GASTRIC DILATATION 1 0.0006
287 GAIT DISTURBANCE 114 0.0006
288 SEIZURE LIKE PHENOMENA 1 0.0006
289 SKIN WOUND 1 0.0006
290 GAZE PALSY 1 0.0006
291 DELUSION 9 0.0006
292 OTORRHOEA 1 0.0006
293 INFUSION SITE DISCHARGE 1 0.0006
294 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
295 INJECTION SITE MASS 21 0.0006
296 FACIAL PARESIS 2 0.0006
297 INJECTION SITE DISCOLOURATION 7 0.0006
298 DEVICE PLACEMENT ISSUE 2 0.0006
299 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
300 SINUS NODE DYSFUNCTION 1 0.0005
301 OESOPHAGEAL SPASM 1 0.0005
302 FEELING DRUNK 4 0.0005
303 INJECTION SITE CELLULITIS 1 0.0005
304 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
305 NARCOLEPSY 1 0.0005
306 MYELOPATHY 1 0.0005
307 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
308 HYPERVENTILATION 3 0.0005
309 PELVIC FRACTURE 4 0.0005
310 CONCOMITANT DISEASE PROGRESSION 1 0.0005
311 HYPOGEUSIA 1 0.0005
312 CONFUSIONAL STATE 82 0.0005
313 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
314 ORAL DISCOMFORT 7 0.0005
315 EMPYEMA 1 0.0005
316 TREMOR 83 0.0005
317 BREAST DISORDER 1 0.0005
318 EUPHORIC MOOD 5 0.0005
319 MANIA 8 0.0005
320 PSYCHOTIC SYMPTOM 1 0.0005
321 DEVICE MALFUNCTION 34 0.0005
322 CHEST INJURY 1 0.0005
323 IMPAIRED SELF-CARE 1 0.0005
324 SKIN INDURATION 1 0.0005
325 INJECTION SITE HAEMATOMA 7 0.0005
326 SUICIDAL BEHAVIOUR 2 0.0005
327 LIVEDO RETICULARIS 1 0.0005
328 PHYSICAL ASSAULT 1 0.0005
329 LUNG ABSCESS 1 0.0005
330 INJECTION SITE BRUISING 38 0.0005
331 SLEEP TERROR 2 0.0005
332 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
333 EYE CONTUSION 1 0.0005
334 PRODUCT DISPENSING ISSUE 2 0.0005
335 OCULOGYRIC CRISIS 1 0.0005
336 TENSION HEADACHE 2 0.0005
337 UNRESPONSIVE TO STIMULI 12 0.0005
338 EXOPHTHALMOS 1 0.0005
339 DEVICE LEAKAGE 20 0.0005
340 NOSOCOMIAL INFECTION 1 0.0005
341 DIZZINESS 225 0.0005
342 HYPERHIDROSIS 58 0.0004
343 WHEELCHAIR USER 2 0.0004
344 PARESIS 1 0.0004
345 LARGE INTESTINAL OBSTRUCTION 1 0.0004
346 MENINGITIS ASEPTIC 2 0.0004
347 FEAR OF DEATH 1 0.0004
348 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
349 HALLUCINATION, AUDITORY 7 0.0004
350 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
351 RIB FRACTURE 9 0.0004
352 MOBILITY DECREASED 31 0.0004
353 FORMICATION 3 0.0004
354 NECK SURGERY 1 0.0004
355 PATELLA FRACTURE 1 0.0004
356 DISCOURAGEMENT 1 0.0004
357 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
358 PUSTULE 1 0.0004
359 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
360 EOSINOPHIL COUNT DECREASED 1 0.0004
361 AGGRESSION 21 0.0004
362 POOR QUALITY SLEEP 9 0.0004
363 GASTROINTESTINAL OBSTRUCTION 1 0.0004
364 INJECTION SITE HAEMORRHAGE 33 0.0004
365 BREATH ODOUR 1 0.0004
366 HAEMATOLOGICAL INFECTION 1 0.0004
367 SENSITIVE SKIN 3 0.0004
368 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
369 ACUTE PSYCHOSIS 1 0.0004
370 HIP FRACTURE 13 0.0004
371 CONSTIPATION 88 0.0004
372 ILEUS 5 0.0004
373 GASTROINTESTINAL TUBE INSERTION 1 0.0004
374 NAUSEA 316 0.0004
375 ABNORMAL DREAMS 11 0.0004
376 ERYSIPELAS 2 0.0004
377 COLD SWEAT 7 0.0004
378 PARKINSON'S DISEASE 1 0.0004
379 ABDOMINAL INFECTION 1 0.0004
380 DISSOCIATION 3 0.0004
381 FEMORAL NECK FRACTURE 2 0.0004
382 NEUROPATHY PERIPHERAL 37 0.0004
383 HYPERSOMNIA 11 0.0004
384 SLEEP DISORDER 27 0.0004
385 AFFECTIVE DISORDER 3 0.0004
386 INJECTION SITE DISCOMFORT 4 0.0004
387 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 27 0.0004
388 RADICULOPATHY 1 0.0004
389 SCRATCH 4 0.0004
390 INCONTINENCE 4 0.0004
391 BLOOD PRESSURE DECREASED 25 0.0004
392 ABDOMINAL DISTENSION 39 0.0004
393 BLOOD SODIUM INCREASED 1 0.0004
394 GAMBLING DISORDER 1 0.0004
395 BACK INJURY 4 0.0004
396 GAIT INABILITY 12 0.0004
397 DEMENTIA 10 0.0004
398 MUSCULOSKELETAL STIFFNESS 31 0.0004
399 CIRCULATORY COLLAPSE 6 0.0004
400 PARANOIA 6 0.0003
401 HEAD INJURY 11 0.0003
402 HYPERTONIC BLADDER 1 0.0003
403 UNINTENTIONAL MEDICAL DEVICE REMOVAL 4 0.0003
404 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
405 COMA SCALE ABNORMAL 1 0.0003
406 HAEMOTHORAX 1 0.0003
407 HYPOKINESIA 5 0.0003
408 DEVICE USE ISSUE 6 0.0003
409 EOSINOPHILIA 6 0.0003
410 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
411 SPINAL OSTEOARTHRITIS 3 0.0003
412 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
413 BLOOD IRON DECREASED 4 0.0003
414 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
415 RESTLESS LEGS SYNDROME 6 0.0003
416 EMERGENCY CARE 1 0.0003
417 EYE INJURY 1 0.0003
418 DEVICE FAILURE 5 0.0003
419 RESTLESSNESS 12 0.0003
420 MEDICAL DEVICE DISCOMFORT 1 0.0003
421 INSURANCE ISSUE 5 0.0003
422 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
423 COGNITIVE DISORDER 15 0.0003
424 PNEUMONIA ASPIRATION 8 0.0003
425 BLOOD BLISTER 1 0.0003
426 PHOTOPSIA 2 0.0003
427 THERAPY CESSATION 16 0.0003
428 PARKINSONISM 3 0.0003
429 URINARY INCONTINENCE 9 0.0003
430 APPETITE DISORDER 2 0.0003
431 SKIN INJURY 1 0.0003
432 NEPHRITIS 1 0.0003
433 TERMINAL STATE 2 0.0003
434 EYE MOVEMENT DISORDER 2 0.0003
435 BRONCHOPNEUMONIA 1 0.0003
436 REGURGITATION 1 0.0003
437 INSOMNIA 77 0.0003
438 DEVICE USE ERROR 10 0.0003
439 SKIN REACTION 4 0.0003
440 LOGORRHOEA 1 0.0003
441 BONE EROSION 1 0.0003
442 RETCHING 6 0.0003
443 URINARY TRACT INFECTION 48 0.0003
444 JOINT INJURY 6 0.0003
445 PRODUCT SUPPLY ISSUE 2 0.0003
446 ABNORMAL BEHAVIOUR 11 0.0003
447 SCLERODERMA 1 0.0003
448 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
449 HYPOPHAGIA 7 0.0003
450 BLOOD GLUCOSE FLUCTUATION 3 0.0003
451 AGITATION 20 0.0003
452 PARADOXICAL DRUG REACTION 1 0.0003
453 EXPIRED PRODUCT ADMINISTERED 9 0.0003
454 SKIN INFECTION 3 0.0003
455 PAROSMIA 2 0.0003
456 LOSS OF CONTROL OF LEGS 1 0.0003
457 INJECTION SITE REACTION 18 0.0003
458 COMMUNICATION DISORDER 1 0.0003
459 INJECTION SITE RASH 8 0.0003
460 LETHARGY 15 0.0003
461 ADVERSE EVENT 24 0.0003
462 LOSS OF CONSCIOUSNESS 33 0.0003
463 LUNG INFECTION 4 0.0003
464 FAECES HARD 1 0.0003
465 APNOEA 2 0.0003
466 CARDIOPULMONARY FAILURE 1 0.0003
467 CHOKING 5 0.0003
468 GASTROINTESTINAL INFLAMMATION 2 0.0003
469 PRODUCT USE COMPLAINT 4 0.0003
470 DEVICE DISLOCATION 11 0.0003
471 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
472 NASAL DISCOMFORT 2 0.0003
473 BLOOD PRESSURE ABNORMAL 5 0.0003
474 HYPERPHAGIA 1 0.0003
475 ATRIAL FLUTTER 2 0.0003
476 SKIN PAPILLOMA 1 0.0002
477 SENSORY DISTURBANCE 4 0.0002
478 RHINITIS 2 0.0002
479 MUSCLE TIGHTNESS 4 0.0002
480 TASTE DISORDER 5 0.0002
481 APPLICATION SITE DISCOLOURATION 1 0.0002
482 RESPIRATORY DEPRESSION 3 0.0002
483 DYSPHAGIA 23 0.0002
484 CONDITION AGGRAVATED 73 0.0002
485 ERECTION INCREASED 1 0.0002
486 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
487 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
488 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
489 POOR PERIPHERAL CIRCULATION 1 0.0002
490 HEPATIC PAIN 1 0.0002
491 RHINORRHOEA 15 0.0002
492 NIGHTMARE 8 0.0002
493 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
494 OCULAR ICTERUS 1 0.0002
495 SYNCOPE 23 0.0002
496 SEDATION 6 0.0002
497 IMMOBILE 1 0.0002
498 CONTUSION 22 0.0002
499 FEELING HOT 14 0.0002
500 DYSPHEMIA 1 0.0002
501 ADVERSE REACTION 3 0.0002
502 RESPIRATORY RATE INCREASED 2 0.0002
503 OROPHARYNGEAL DISCOMFORT 2 0.0002
504 DEPRESSION 50 0.0002
505 LUMBAR VERTEBRAL FRACTURE 1 0.0002
506 LOCALISED OEDEMA 1 0.0002
507 ARTHRITIS INFECTIVE 1 0.0002
508 COORDINATION ABNORMAL 3 0.0002
509 MIDDLE INSOMNIA 4 0.0002
510 SKIN ABRASION 1 0.0002
511 BLOOD PRESSURE FLUCTUATION 5 0.0002
512 VOMITING 97 0.0002
513 HORMONE LEVEL ABNORMAL 1 0.0002
514 NASAL CONGESTION 12 0.0002
515 LIVER INJURY 5 0.0002
516 FATIGUE 158 0.0002
517 DISORIENTATION 8 0.0002
518 HAEMATOCRIT DECREASED 4 0.0002
519 DELIRIUM 7 0.0002
520 HYPERNATRAEMIA 1 0.0002
521 APPLICATION SITE SWELLING 1 0.0002
522 HYPOTONIA 2 0.0002
523 FLUID INTAKE REDUCED 1 0.0002
524 IRRITABILITY 12 0.0002
525 OSTEOPENIA 3 0.0002
526 MEMORY IMPAIRMENT 27 0.0002
527 SUBARACHNOID HAEMORRHAGE 2 0.0002
528 SLUGGISHNESS 2 0.0002
529 PETIT MAL EPILEPSY 1 0.0002
530 DEVICE ADHESION ISSUE 3 0.0002
531 INITIAL INSOMNIA 2 0.0002
532 POLLAKIURIA 8 0.0002
533 MALABSORPTION 1 0.0002
534 BLOOD LACTIC ACID INCREASED 1 0.0002
535 EATING DISORDER 4 0.0002
536 COMPRESSION FRACTURE 1 0.0002
537 INJECTION SITE DISCHARGE 1 0.0002
538 JAUNDICE 5 0.0002
539 GINGIVITIS 1 0.0002
540 LIMB INJURY 5 0.0002
541 SKIN LACERATION 2 0.0002
542 FAECALOMA 1 0.0002
543 INTESTINAL ISCHAEMIA 1 0.0002
544 CHOKING SENSATION 1 0.0002
545 HYPERKERATOSIS 1 0.0002
546 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
547 GASTRIC ULCER HAEMORRHAGE 1 0.0002
548 FOOT DEFORMITY 2 0.0002
549 MENTAL STATUS CHANGES 5 0.0002
550 HEART RATE ABNORMAL 1 0.0002
551 CHROMATURIA 4 0.0002
552 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
553 GENERALISED ERYTHEMA 1 0.0002
554 MYOCARDIAL ISCHAEMIA 2 0.0002
555 HYPERTONIA 1 0.0002
556 MOUTH SWELLING 1 0.0002
557 OEDEMA PERIPHERAL 21 0.0002
558 RALES 1 0.0002
559 RASH MACULAR 6 0.0002
560 DYSSTASIA 5 0.0002
561 FEELING ABNORMAL 41 0.0002
562 DECREASED INTEREST 1 0.0002
563 HEAD DISCOMFORT 3 0.0002
564 ATAXIA 2 0.0002
565 THERAPY INTERRUPTED 12 0.0002
566 WRIST FRACTURE 2 0.0002
567 GANGRENE 1 0.0002
568 PANIC ATTACK 6 0.0002
569 LIMB DISCOMFORT 5 0.0002
570 FEMUR FRACTURE 5 0.0002
571 OLIGURIA 1 0.0002
572 THINKING ABNORMAL 3 0.0002
573 PHOTOPHOBIA 3 0.0002
574 DERMATITIS ALLERGIC 2 0.0002
575 BLEPHAROSPASM 1 0.0002
576 CELLULITIS 8 0.0002
577 BRAIN OEDEMA 2 0.0002
578 FOOT FRACTURE 3 0.0002
579 FEELING JITTERY 3 0.0002
580 CYSTITIS 5 0.0002
581 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
582 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
583 ERUCTATION 3 0.0002
584 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
585 BEDRIDDEN 2 0.0002
586 PRODUCT FORMULATION ISSUE 1 0.0002
587 SINUS DISORDER 3 0.0002
588 DEPRESSED MOOD 8 0.0002
589 CORONAVIRUS INFECTION 1 0.0002
590 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
591 URINARY RETENTION 5 0.0001
592 SPINAL FRACTURE 3 0.0001
593 PRODUCT PHYSICAL ISSUE 3 0.0001
594 PRODUCT ADMINISTRATION ERROR 3 0.0001
595 MALAISE 65 0.0001
596 SINUS CONGESTION 2 0.0001
597 FEEDING DISORDER 3 0.0001
598 ANGER 5 0.0001
599 BODY TEMPERATURE INCREASED 3 0.0001
600 IMPAIRED GASTRIC EMPTYING 2 0.0001
601 MOOD ALTERED 4 0.0001
602 ECCHYMOSIS 1 0.0001
603 INJECTION SITE WARMTH 3 0.0001
604 TOOTH LOSS 3 0.0001
605 LARGE INTESTINE PERFORATION 1 0.0001
606 ASTHENIA 54 0.0001
607 CARDIO-RESPIRATORY ARREST 6 0.0001
608 HOSPITALISATION 22 0.0001
609 DERMATITIS 3 0.0001
610 CARPAL TUNNEL SYNDROME 2 0.0001
611 PERIPHERAL SWELLING 22 0.0001
612 HAND FRACTURE 1 0.0001
613 MUSCULAR WEAKNESS 16 0.0001
614 INTENTIONAL DOSE OMISSION 4 0.0001
615 CEREBRAL HAEMORRHAGE 5 0.0001
616 PARAESTHESIA ORAL 2 0.0001
617 PRODUCT DISPENSING ERROR 3 0.0001
618 APATHY 2 0.0001
619 BLINDNESS TRANSIENT 1 0.0001
620 DRY MOUTH 11 0.0001
621 ARTHROPOD BITE 1 0.0001
622 SKIN HAEMORRHAGE 2 0.0001
623 NERVOUSNESS 7 0.0001
624 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
625 HAEMORRHAGE INTRACRANIAL 2 0.0001
626 KETOACIDOSIS 1 0.0001
627 ADVERSE DRUG REACTION 12 0.0001
628 PEMPHIGOID 1 0.0001
629 APHASIA 4 0.0001
630 LACRIMATION INCREASED 4 0.0001
631 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
632 PRODUCT AVAILABILITY ISSUE 3 0.0001
633 HAEMODYNAMIC INSTABILITY 1 0.0001
634 SKIN IRRITATION 6 0.0001
635 ACIDOSIS 1 0.0001
636 HIP ARTHROPLASTY 2 0.0001
637 SKIN DISCOLOURATION 6 0.0001
638 HEADACHE 81 0.0001
639 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
640 SWOLLEN TONGUE 4 0.0001
641 FLUSHING 13 0.0001
642 PULMONARY HAEMORRHAGE 1 0.0001
643 DRUG DOSE OMISSION BY DEVICE 10 0.0001
644 PNEUMOTHORAX 2 0.0001
645 COMA 6 0.0001
646 GINGIVAL PAIN 1 0.0001
647 BLOOD DISORDER 1 0.0001
648 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
649 SENSORY LOSS 1 0.0001
650 BACK DISORDER 2 0.0001
651 VIRAL INFECTION 4 0.0001
652 PRODUCT DOSE OMISSION ISSUE 35 0.0001
653 UNEVALUABLE EVENT 9 0.0001
654 SENSATION OF FOREIGN BODY 1 0.0001
655 FACIAL PARALYSIS 1 0.0001
656 VISION BLURRED 16 0.0001
657 CARDIAC MURMUR 1 0.0001
658 ILL-DEFINED DISORDER 7 0.0001
659 SKIN SWELLING 1 0.0001
660 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
661 GRIP STRENGTH DECREASED 1 0.0001
662 FACIAL PAIN 1 0.0001
663 DYSPEPSIA 11 0.0001
664 GASTROENTERITIS VIRAL 2 0.0001
665 ACCIDENTAL OVERDOSE 4 0.0001
666 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
667 ANXIETY 31 0.0001
668 RESPIRATORY ARREST 3 0.0001
669 RETINAL DETACHMENT 1 0.0001
670 HYPERTENSION 23 0.0001
671 PERSONALITY CHANGE 1 0.0001
672 AGRANULOCYTOSIS 2 0.0001
673 SEPSIS 12 0.0001
674 NECK PAIN 6 0.0001
675 WOUND 3 0.0001
676 BACTERIAL INFECTION 2 0.0001
677 PRODUCT USE ISSUE 20 0.0001
678 CEREBROVASCULAR ACCIDENT 18 0.0001
679 INTESTINAL OBSTRUCTION 4 0.0001
680 FLATULENCE 6 0.0001
681 FRACTURE 2 0.0001
682 PRODUCTIVE COUGH 5 0.0001
683 RASH ERYTHEMATOUS 5 0.0001
684 POST PROCEDURAL COMPLICATION 2 0.0001
685 BLOOD GLUCOSE DECREASED 5 0.0001
686 MUSCLE SPASMS 19 0.0001
687 ATELECTASIS 1 0.0001
688 ATRIAL FIBRILLATION 10 0.0001
689 KIDNEY INFECTION 2 0.0001
690 HEPATOMEGALY 1 0.0001
691 TACHYCARDIA 9 0.0001
692 EMBEDDED DEVICE 1 0.0001
693 INABILITY TO AFFORD MEDICATION 1 0.0001
694 UPPER LIMB FRACTURE 2 0.0001
695 RESPIRATORY DISORDER 3 0.0001
696 BURNING SENSATION 7 0.0001
697 BRAIN INJURY 1 0.0001
698 DECREASED APPETITE 23 0.0001
699 SUICIDE ATTEMPT 6 0.0001
700 EPILEPSY 3 0.0001
701 MOTOR DYSFUNCTION 1 0.0001
702 DRUG ADMINISTRATION ERROR 3 0.0001
703 EAR DISCOMFORT 1 0.0001
704 ERYTHEMA 20 0.0001
705 ILLNESS 10 0.0001
706 VISUAL IMPAIRMENT 12 0.0001
707 INFECTION 14 0.0001
708 PERITONITIS 2 0.0001
709 EYE DISCHARGE 1 0.0001
710 ROAD TRAFFIC ACCIDENT 4 0.0001
711 PRODUCT ODOUR ABNORMAL 1 0.0001
712 SEIZURE 11 0.0001
713 JOINT DISLOCATION 1 0.0001
714 RENAL PAIN 1 0.0001
715 DYSGEUSIA 7 0.0001
716 NIGHT SWEATS 3 0.0001
717 DISTURBANCE IN ATTENTION 5 0.0001
718 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
719 RASH PRURITIC 5 0.0001
720 CHEST PAIN 17 0.0001
721 EMOTIONAL DISTRESS 11 0.0001
722 DEVICE DIFFICULT TO USE 6 0.0001
723 DENTAL CARIES 1 0.0001
724 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
725 DEHYDRATION 12 0.0001
726 SKIN DISORDER 3 0.0001
727 PULMONARY OEDEMA 4 0.0001
728 SNEEZING 2 0.0001
729 OXYGEN SATURATION DECREASED 5 0.0001
730 FISTULA 1 0.0001
731 INJECTION SITE PAIN 27 0.0001
732 IMPAIRED DRIVING ABILITY 1 0.0001
733 CHOLECYSTECTOMY 1 0.0001
734 MYOCARDITIS 1 0.0001
735 NEPHROLITHIASIS 4 0.0001
736 HYPOAESTHESIA 13 0.0001
737 PRODUCT SUBSTITUTION ISSUE 5 0.0001
738 MUSCLE TWITCHING 2 0.0001
739 DYSPNOEA 49 0.0001
740 WEIGHT DECREASED 24 0.0001
741 PALPITATIONS 10 0.0001
742 SURGERY 5 0.0001
743 BLOOD PRESSURE INCREASED 13 0.0001
744 COVID-19 PNEUMONIA 1 0.0001
745 DISEASE PROGRESSION 10 0.0001
746 CHOLECYSTITIS 1 0.0001
747 POLYNEUROPATHY 1 0.0001
748 HEPATITIS C 1 0.0001
749 LOCALISED INFECTION 2 0.0001
750 PARAESTHESIA 13 0.0001
751 NO THERAPEUTIC RESPONSE 1 0.0001
752 DISCOMFORT 5 0.0001
753 DRUG INTERACTION 13 0.0001
754 CEREBRAL INFARCTION 2 0.0001
755 INJECTION SITE URTICARIA 2 0.0001
756 MUSCLE SPASTICITY 1 0.0001
757 INJECTION SITE EXTRAVASATION 1 0.0001
758 PYREXIA 28 0.0001
759 PHARYNGITIS 1 0.0001
760 APPLICATION SITE IRRITATION 1 0.0001
761 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
762 MUSCLE ATROPHY 1 0.0001
763 HAEMATEMESIS 2 0.0001
764 CARDIOVASCULAR DISORDER 2 0.0001
765 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
766 URTICARIA 13 0.0001
767 INFLAMMATION 4 0.0001
768 BACK PAIN 18 0.0001
769 SKIN ULCER 2 0.0001
770 HIATUS HERNIA 1 0.0001
771 HAEMATOMA 2 0.0001
772 AMNESIA 5 0.0001
773 APPLICATION SITE ERYTHEMA 2 0.0001
774 PULMONARY CONGESTION 1 0.0001
775 CARDIAC DISORDER 7 0.0001
776 PAIN IN EXTREMITY 22 0.0001
777 QUALITY OF LIFE DECREASED 1 0.0001
778 EXTRA DOSE ADMINISTERED 3 0.0001
779 THROAT TIGHTNESS 2 0.0001
780 PNEUMONITIS 2 0.0001
781 ANAEMIA 14 0.0001
782 AKATHISIA 1 0.0001
783 DEVICE MECHANICAL ISSUE 1 0.0001
784 CORONARY ARTERY OCCLUSION 1 0.0001
785 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
786 COMPLETED SUICIDE 6 0.0001
787 WITHDRAWAL SYNDROME 3 0.0001
788 BLINDNESS UNILATERAL 1 0.0001
789 EYE PAIN 4 0.0001
790 LYMPHOPENIA 1 0.0001
791 HEART RATE INCREASED 7 0.0001
792 PAIN IN JAW 2 0.0001
793 BRONCHOSPASM 1 0.0001
794 RED BLOOD CELL COUNT DECREASED 2 0.0001
795 PARALYSIS 1 0.0001
796 HYPOACUSIS 3 0.0001
797 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
798 ANOSMIA 1 0.0001
799 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
800 NEEDLE ISSUE 2 0.0001
801 INTENTIONAL PRODUCT MISUSE 6 0.0001
802 PNEUMONIA 22 0.0001
803 COLON CANCER 1 0.0001
804 GASTROINTESTINAL DISORDER 6 0.0001
805 HAEMORRHAGE 7 0.0001
806 RASH 29 0.0001
807 VERTIGO 4 0.0001
808 SUICIDAL IDEATION 6 0.0001
809 LYMPHOMA 1 0.0001
810 MUSCULOSKELETAL CHEST PAIN 1 0.0001
811 ANKLE FRACTURE 1 0.0001
812 ARRHYTHMIA 3 0.0001
813 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
814 DRUG INTOLERANCE 6 0.0001
815 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
816 DEEP VEIN THROMBOSIS 4 0.0001
817 LUNG DISORDER 3 0.0001
818 EYE DISORDER 2 0.0001
819 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
820 DEATH 52 0.0001
821 COAGULOPATHY 1 0.0001
822 NEOPLASM MALIGNANT 4 0.0001
823 CHILLS 7 0.0001
824 FACE OEDEMA 1 0.0001
825 CANDIDA INFECTION 1 0.0001
826 FLUID RETENTION 3 0.0001
827 HAEMOGLOBIN DECREASED 6 0.0001
828 MYOCARDIAL INFARCTION 10 0.0001
829 DRUG WITHDRAWAL SYNDROME 5 0.0001
830 METASTASES TO LIVER 1 0.0001
831 HYPOXIA 2 0.0001
832 LYMPHOCYTE COUNT DECREASED 1 0.0001
833 BRADYCARDIA 3 0.0001
834 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
835 DRUG ERUPTION 1 0.0001
836 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
837 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
838 OSTEOMYELITIS 1 0.0001
839 PELVIC PAIN 1 0.0001
840 CRYING 2 0.0001
841 C-REACTIVE PROTEIN INCREASED 2 0.0001
842 HYPERGLYCAEMIA 2 0.0001
843 DYSURIA 2 0.0001
844 MEDICATION ERROR 3 0.0001
845 ABDOMINAL DISCOMFORT 9 0.0001
846 THROMBOCYTOPENIA 6 0.0001
847 BLOOD SODIUM DECREASED 1 0.0001
848 MYALGIA 9 0.0001
849 RENAL FAILURE 7 0.0001
850 BLOOD URINE PRESENT 1 0.0001
851 LOWER LIMB FRACTURE 1 0.0001
852 GLAUCOMA 1 0.0001
853 HERNIA 1 0.0001
854 DRUG INEFFECTIVE 68 0.0001
855 EAR PAIN 1 0.0001
856 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
857 OVERDOSE 11 0.0001
858 WHEEZING 3 0.0001
859 PAIN 31 0.0001
860 CATARACT 3 0.0001
861 INJURY ASSOCIATED WITH DEVICE 1 0.0000
862 CHEST DISCOMFORT 5 0.0000
863 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
864 LIVER FUNCTION TEST INCREASED 1 0.0000
865 SKIN CANCER 1 0.0000
866 COUGH 13 0.0000
867 DEVICE EXPULSION 3 0.0000
868 PRURITUS GENERALISED 1 0.0000
869 SWELLING FACE 3 0.0000
870 MENTAL DISORDER 2 0.0000
871 PRODUCT PRESCRIBING ISSUE 1 0.0000
872 MELAENA 1 0.0000
873 LIVER DISORDER 2 0.0000
874 INFLUENZA 5 0.0000
875 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
876 HEART RATE IRREGULAR 1 0.0000
877 INCORRECT DOSE ADMINISTERED 10 0.0000
878 ABDOMINAL PAIN UPPER 9 0.0000
879 TINNITUS 2 0.0000
880 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
881 PERICARDIAL EFFUSION 1 0.0000
882 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
883 MIGRAINE 4 0.0000
884 PRURITUS 16 0.0000
885 JOINT SWELLING 5 0.0000
886 INTERSTITIAL LUNG DISEASE 2 0.0000
887 MENTAL IMPAIRMENT 1 0.0000
888 HYPOGLYCAEMIA 2 0.0000
889 RESPIRATORY FAILURE 3 0.0000
890 FIBROMYALGIA 1 0.0000
891 ENCEPHALOPATHY 1 0.0000
892 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
893 EPISTAXIS 3 0.0000
894 AGEUSIA 1 0.0000
895 HOT FLUSH 3 0.0000
896 GASTRIC CANCER 1 0.0000
897 HEPATITIS 1 0.0000
898 ABDOMINAL PAIN 9 0.0000
899 RASH GENERALISED 1 0.0000
900 RESPIRATORY TRACT INFECTION 1 0.0000
901 ECZEMA 2 0.0000
902 GASTRITIS 1 0.0000
903 NASOPHARYNGITIS 7 0.0000
904 EAR INFECTION 1 0.0000
905 DRUG DEPENDENCE 6 0.0000
906 DIARRHOEA 24 0.0000
907 FEAR 1 0.0000
908 DRUG EFFECT DECREASED 2 0.0000
909 BLOOD BILIRUBIN INCREASED 1 0.0000
910 OEDEMA 2 0.0000
911 PRODUCT QUALITY ISSUE 5 0.0000
912 TREATMENT NONCOMPLIANCE 2 0.0000
913 SKIN LESION 1 0.0000
914 INFLUENZA LIKE ILLNESS 3 0.0000
915 RESPIRATORY DISTRESS 1 0.0000
916 DIVERTICULITIS 1 0.0000
917 DRUG ABUSE 3 0.0000
918 HAEMOPTYSIS 1 0.0000
919 RENAL IMPAIRMENT 3 0.0000
920 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
921 ANGINA PECTORIS 1 0.0000
922 HERPES ZOSTER 2 0.0000
923 PANCREATIC CARCINOMA 1 0.0000
924 LIVER FUNCTION TEST ABNORMAL 1 0.0000
925 RENAL INJURY 1 0.0000
926 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
927 EMOTIONAL DISORDER 1 0.0000
928 OROPHARYNGEAL PAIN 3 0.0000
929 HYPERSENSITIVITY 6 0.0000
930 PULMONARY EMBOLISM 3 0.0000
931 MOOD SWINGS 1 0.0000
932 HYPOTHYROIDISM 1 0.0000
933 METABOLIC ACIDOSIS 1 0.0000
934 ARTHRALGIA 13 0.0000
935 INTENTIONAL OVERDOSE 2 0.0000
936 CHOLELITHIASIS 1 0.0000
937 IMPAIRED HEALING 1 0.0000
938 FUNGAL INFECTION 1 0.0000
939 SINUSITIS 3 0.0000
940 GASTRIC DISORDER 1 0.0000
941 LYMPHADENOPATHY 1 0.0000
942 BRONCHITIS 2 0.0000
943 EYE SWELLING 1 0.0000
944 HEPATIC FUNCTION ABNORMAL 1 0.0000
945 ARTHRITIS 2 0.0000
946 CARDIAC FAILURE CONGESTIVE 2 0.0000
947 THROMBOSIS 2 0.0000
948 BLINDNESS 1 0.0000
949 LUNG NEOPLASM MALIGNANT 1 0.0000
950 OSTEOPOROSIS 1 0.0000
951 CARDIAC ARREST 2 0.0000
952 TREATMENT FAILURE 2 0.0000
953 RHABDOMYOLYSIS 1 0.0000
954 SKIN EXFOLIATION 2 0.0000
955 OSTEOARTHRITIS 1 0.0000
956 RENAL FAILURE ACUTE 1 0.0000
957 RECTAL HAEMORRHAGE 1 0.0000
958 SEPTIC SHOCK 1 0.0000
959 ANGIOEDEMA 1 0.0000
960 HYPOKALAEMIA 1 0.0000
961 RENAL DISORDER 1 0.0000
962 BLOOD CHOLESTEROL INCREASED 1 0.0000
963 DISEASE RECURRENCE 1 0.0000
964 ALOPECIA 4 0.0000
965 LEUKOPENIA 1 0.0000
966 ACUTE KIDNEY INJURY 3 0.0000
967 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
968 MUSCULOSKELETAL PAIN 1 0.0000
969 PANCREATITIS 1 0.0000
970 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
971 DEPENDENCE 1 0.0000
972 TOXICITY TO VARIOUS AGENTS 3 0.0000
973 HYPONATRAEMIA 1 0.0000
974 ASTHMA 2 0.0000
975 EYE IRRITATION 1 0.0000
976 PLEURAL EFFUSION 1 0.0000
977 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
978 OFF LABEL USE 14 0.0000
979 BLOOD GLUCOSE INCREASED 3 0.0000
980 BLOOD CREATININE INCREASED 1 0.0000
981 FEBRILE NEUTROPENIA 1 0.0000
982 DRY SKIN 2 0.0000
983 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
984 INJURY 1 0.0000
985 SKIN BURNING SENSATION 1 0.0000
986 WEIGHT INCREASED 3 0.0000
987 ACNE 1 0.0000
988 PRODUCT STORAGE ERROR 1 0.0000
989 BREAST CANCER 1 0.0000
990 PLATELET COUNT DECREASED 1 0.0000
991 PSORIASIS 1 0.0000